478
H. R. Kalita and P. Phukan
N-Benzyloxycarbonyl-1-(4-bromophenyl) but-3-enylamine (4b): White
solid; mp 87–888C. IR (Nujol, cm21): 3055, 1714, 1598, 1418, 1266, 748. 1H
NMR (400 MHz, CDCl3): 7.44 (d, J ¼ 8.1 Hz, 2H), 7.40–7.25 (m, 5H), 7.13
(d, J ¼ 7.7 Hz, 2H), 5.72–5.54 (m, 1H), 5.22–4.96 (m, 5H), 4.82–4.65
(m, 1H), 2.60–2.36 (m, 2H). 13C NMR (100 MHz, CDCl3): 155.6, 141.0,
136.2, 133.2, 131.6, 128.5, 128.2, 127.9, 121.1, 118.9, 66.9, 53.9, 40.8. MS
(m/z, % rel. intensity): 320 (8), 274 (10), 253 (6) 185 (36), 105 (34), 91
(100), 77 (41), 65 (6). Anal. Calcd for C18H18BrNO2: C, 60.01; H, 5.03; N,
3.89. Found: C, 59.97; H, 5.07; N, 3.84.
N-Benzyloxycarbonyl-1-(4-methoxyphenyl)but-3-enylamine (4c): White
solid; mp 70–718C (Lit.[24] mp (for S-(2)-enantiomer 67–688C). IR (Nujol,
1
cm21): 3055, 1719, 1506, 1427, 1266, 739. H NMR (400 MHz, CDCl3):
7.41–7.29 (m, 5H), 7.19 (d, J ¼ 7.8 Hz, 2H), 6.86 (d, J ¼ 8.6 Hz, 2H),
5.77–5.58 (m, 1H), 5.20–5.00 (m, 5H), 4.80–4.70 (m, 1H), 3.79 (s, 3H),
2.60–2.54 (m, 2H). 13C NMR (100 MHz, CDCl3): 158.7, 155.6, 136.4,
133.9, 128.4, 128.0, 127.3, 118.2, 113.8, 86.7, 55.2, 53.9, 40.9. MS (m/z,
% rel. intensity): 270 (40), 226 (54), 162 (6), 134 (6), 107 (2), 91 (100), 77
(2), 65 (4). Anal. Calcd for C19H21NO3: C, 73.29; H, 6.80; N, 4.50. Found:
C, 73.25; H, 6.82; N, 4.54.
N-Benzyloxycarbonyl-1-(3-chlorophenyl)but-3-enylamine (4d): White
solid; mp 62–638C. IR (Nujol, cm21): 3055, 1714, 1506, 1266, 739, 702.
1H NMR (400 MHz, CDCl3): 7.41–7.17 (m, 8H), 7.12 (d, J ¼ 6.3 Hz, 1H),
5.72–5.51 (m, 1H), 5.21–4.93 (m 5H), 4.82–4.68 (m, 1H), 2.59–2.36
(m, 2H); 13C NMR (100 MHz, CDCl3): 155.6, 136.2, 134.4, 133.1, 129.8,
128.5, 128.2, 127.5, 126.3, 124.5, 119.0, 66.9, 53.9, 40.9. MS (m/z, %
rel. intensity): 274 (12), 230(18), 166 (5),141 (67), 113 (25), 91 (100), 77
(42), 65 (5). Anal. Calcd for C18H18ClNO2: C, 68.46; H, 5.74; N, 4.43.
Found: C, 68.42; H, 5.69; N, 4.48.
N-Benzyloxycarbonyl-1-(4-nitrophenyl)but-3-enylamine (4e): White
solid; mp 88–898C. IR (Nujol, cm21): 3047, 2307, 1719, 1516, 1266, 739.
1H NMR (400 MHz, CDCl3): 8.1 (d, J ¼ 7.8 Hz, 2H), 7.50–6.92 (m, 7H),
5.65–5.45 (m, 1H), 5.23–4.91 (m, 5H), 4.86–4.72 (m, 1H), 2.56–2.30
(m, 2H). 13C NMR (100 MHz, CDCl3): 155.5, 149.6, 147.1, 132.4, 128.5,
128.3, 128.2, 127.0, 123.8, 119.7, 67.7, 54.1, 40.7. MS (m/z, %
rel. intensity): 285 (6), 241 (13), 191 (2), 177 (2), 152 (16), 108 (4), 91
(100), 77 (4), 65 (4). Anal. Calcd. for C18H18N2O4: C, 66.25; H, 5.56; N,
8.58. Found: 66.29; H, 5.51; N, 8.63.
N-Benzyloxycarbonyl-1-benzylbut-3-enylamine (4f): White solid; mp
1
86–878C. IR (Nujol, cm21): 3065, 1701, 1520, 1446, 1252, 1040, 744. H
NMR (400 MHz, CDCl3): 7.52–7.07 (m, 10H), 5.88–5.70 (m, 1H), 5.17-
5.00 (m, 4H), 4.65 (d, J ¼ 6.8 Hz, 1H), 4.06–3.88 (m, 1H), 2.91–2.68
(m, 2H), 2.36–2.23 (m, 1H), 2.21 ¼ 2.04 (m, 1H). 13C NMR (100 MHz,
CDCl3): 155.7, 137.8, 136.6, 134.1, 129.4, 128.5 128.4, 128.0, 128.0,
126.4, 118.2, 66.5, 51.6, 40.4, 38.1. MS (m/z, % rel. intensity): 254 (4),